Ascendis Pharma A (ASND) Current Leases (2019 - 2023)

Ascendis Pharma A has reported Current Leases for 7 years, with the latest figure at $176.4 million in Q4 2025.

• Quarterly Current Leases rose 77.42% year-over-year to $176.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $176.4 million (up 77.42% YoY) and the FY2025 annual result came in at $176.4 million, up 77.42% from the prior year.
• Current Leases grew to $176.4 million in Q4 2025 per ASND's latest filing, from $99.4 million in the prior quarter.
• Over five years, Current Leases peaked at $176.4 million in Q4 2025 and troughed at $15.3 million in Q4 2023.
• A 5-year average of $104.5 million and a median of $108.0 million in 2021 frame the typical range for Current Leases.
• The sharpest annual moves came in 2023 and 2024: Current Leases slumped 84.3% in 2023, then jumped 550.67% in 2024.
• Over 5 years, Current Leases stood at $120.1 million in 2021, then slipped by 18.94% to $97.3 million in 2022, then plunged by 84.3% to $15.3 million in 2023, then surged by 550.67% to $99.4 million in 2024, then jumped by 77.42% to $176.4 million in 2025.
• According to Business Quant data, Current Leases over the past three periods registered $176.4 million, $99.4 million, and $15.3 million for Q4 2025, Q4 2024, and Q4 2023 respectively.